A patient decision aid for systemic lupus erythematosus improves shared decision-making and patient-provider communication in ...

In the final part of her interview, Margrit Wiesendanger, MD, PhD, discusses the need to improve lupus care by addressing social determinants of health and expanding access to treatment. In the fourth ...

In this recording from the event, specialists discuss the impact of lupus on oral health. We reveal how lupus treatments may play a role in the development of dental issues, give tips for accessing ...

Leaders of a project to develop and implement equitable new quality measures for lupus care by the end of the decade will present their work at ACR Convergence 2023, the American College of ...

Trial met primary endpoint achieving statistically significant improvement in disease activity, with 67.1% of patients ...

Margrit Wiesendanger, MD, PhD, highlights how social determinants of health and equitable treatment access are critical to improving lupus outcomes, particularly in minority populations. The LUMINA ...

DENVER — Neuropsychiatric lupus is “arguably the least understood manifestation” of systemic lupus erythematosus (SLE) in children, with patients facing substantial barriers and experiencing highly ...

First HopeHealth Clinical Trial Marks Major Milestone for Access to Medical Research in Rural South Carolina Originally published on HopeHealth NORTHAMPTON, MA / ACCESS Newswire / October 16, 2025 / ...

Adicet Bio reported strong Phase 1 lupus trial results with ADI-001, showing 100% response in nephritis patients and raising ...